ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Life sciences executive Dr Georgia Papathomas joins Indegene’s Board as Independent Director

PRINCETON, N.J. and BANGALORE, India, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Georgia Papathomas as a Non-Executive Independent Director to the Board.

Georgia brings several years of experience in life sciences. She works closely with many innovative healthcare and technology companies as an advisor and board member. Georgia worked at Johnson & Johnson in her last corporate role.

“Life sciences companies are increasingly looking to personalize the patient and physician experience through omnichannel journeys. They are aiming to transform operations across the commercialization value chain with a digital-first approach,” said Manish Gupta, CEO, Indegene. “I am excited to welcome Georgia to our Board at this interesting time in the industry. Her experience in building and managing teams at various life sciences companies, coupled with her engagement with new-age health-tech startups, will help us greatly as we prepare for Indegene’s next phase of growth.”

“Indegene is helping global life sciences organizations in an increasingly complex business environment. The company is propelled by an experienced leadership team, with a deep understanding of the sector and a focus on execution at scale,” said Georgia Papathomas, Independent Director, Indegene. “I am excited to join Indegene’s Board in their growth journey and I look forward to supporting the company’s future endeavors using my experience in leading innovative, diverse global teams around the world.”

Georgia is an executive advisory board member of numerous organizations, including the Executive Board of the National Center for Women & Information Technology, the Board of Advisor of Homeless Solutions, Inc., and Columbia University School of Engineering and Applied Science (also known as Fu Foundation School of Engineering and Applied Science).

About Indegene
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready. To learn more, please visit www.indegene.com

For media inquiries, please contact:
Yadunandan K V | yadunandan.kv@indegene.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.